Abstract:Preclinical efficacy and toxicity assessment of drug candidates plays a significant role in drug discovery and development. Traditional planar cell culture is a common way to perform the preclinical drug test, but it is difficult to correctly predict the drug efficacy and toxicity due to the simple two-dimensional (2D) extracellular microenvironment. Compared to the planar cell culture, three-dimensional (3D) cell culture system can better mimic the complex extracellular microenvironment where cells reside in the 3D tissues/organs in vivo. However, the conventional imaging techniques are difficult to achieve the dynamic and label-free monitoring of cellular behavior in thick sample by 3D cell culture. Here, 3D electric cell/matrigel-substrate impedance sensing (3D-ECMIS) is developed for real-time and non-invasive monitoring of 3D cell viability and drug susceptibility. In this study, human hepatoma cells (HepG2) are encapsulated in the matrigel scaffold and cultured in a 3D ECMIS chip which involves a pair of vertical golden electrodes on the opposite sidewalls of the culture chamber for the in-situ impedance measurement. Moreover, a portable multichannel system is developed to monitor the 3D cell/matrigel construct. The number of 3D-cultured cells was inversely proportional to the impedance magnitude of the entire cell/matrigel construct. Furthermore, anti-cancer drug screening will be conducted on the 3D-cultured cells when the cell proliferation reaches to a plateau phase. To validate the performance of 3D-ECMIS for the cell viability and drug susceptibility, the cell live/dead staining are utilized to confirm the results of drug susceptibility by this 3D-cell-based biosensor system. It is demonstrated that the 3D cell-based biosensor and 3D-ECMIS system will be a promising platform to improve the accuracy of cell-based anti-cancer drug screening in vitro.

Drug evaluations using a novel microphysiometer based on cell-based biosensors

A Novel Multi-Functional Cell-Based Microphysiometer

Integrated Cell-Based Biosensor for Extracellular Electrophysiological Monitoring

A novel microphysiometer based on MLAPS for drugs screening.

The Single-Cell Biosensor For Monitoring Extracellular Action Potential And Evaluating Drugs

Microfluidic Chip System Integrated with Light Addressable Potentiometric Sensor (LAPS) for Real-Time Extracellular Acidification Detection

3D Cell-Based Biosensor for Cell Viability and Drug Assessment by 3D Electric Cell/matrigel-Substrate Impedance Sensing.

In Vitro Assessing the Risk of Drug-Induced Cardiotoxicity by Embryonic Stem Cell-Based Biosensor

Cell-Based Biosensors for Single Cell Monitoring and Drug Analysis

Cardiac Cell-based Biosensor and Its Biomedical Applications

Beating Cardiac Cell-Based Biosensor and Its Application in Drugs Screening

Cell-based biosensors based on light-addressable potentiometric sensors for single cell monitoring.

A Novel Micro-Groove Impedance Sensor for 3D Cell Viability Monitoring and High-Throughput Drug Screening

A novel design of multifunctional integrated cell-based biosensors for simultaneously detecting cell acidification and extracellular potential

A Conductive Hydrogel-Paper Sensor for Cell Metabolism Monitoring

Application Research of the Microelectronic Cell Sensor in Drug Analysis of Anti-Cancer

Design and drug analysis based on light addressable single cell biosensor

DESIGN OF MICROPHYSIOMETER BASED ON MULTIPARAMETER CELL-BASED BIOSENSORS FOR QUICK DRUG ANALYSIS

A novel microphysiometer based on high sensitivity LAPS and microfluidic system for cellular metabolism study and rapid drug screening.

A microsensing system for the in vivo real-time monitoring of local drug kinetics

A cardiomyocyte-based biosensor for antiarrhythmic drug evaluation by simultaneously monitoring cell growth and beating.